VILDAILY-DM SR

MRP

MRP 147.18/-Strip

Description

• Each uncoated bilayered tablet contains : Vildagliptin IP 100mg (as sustained release form) Dapagliflozin Propanediol eq. to Dapagliflozin 10mg + Metfromin Hydrochloride IP 500mg (as sustained release form) Excipients q.s. 

Doses

• As directed by the Physician

Indication

• The combination of dapagliflozin, metformin, and vildagliptin is used to treat type 2 diabetes mellitus by lowering blood sugar levels through multiple mechanisms